Exact Mass: 465.1152202
Exact Mass Matches: 465.1152202
Found 36 metabolites which its exact mass value is equals to given mass value 465.1152202
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cys Asp Asp Asn
Cys Asp Asn Asp
Cys Asn Asp Asp
Asp Cys Asp Asn
Asp Cys Asn Asp
Asp Asp Cys Asn
Asp Asp Asn Cys
Asp Asn Cys Asp
Asp Asn Asp Cys
Asn Cys Asp Asp
Asn Asp Cys Asp
Asn Asp Asp Cys
METHYL 3,4,6-TRI-O-ACETYL-2-DEOXY-2-PHTHALIMIDO-1-THIO-BETA-D-GLUCOPYRANOSIDE
Diphenylpiperidinomethyldioxolan iodide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
6-Chloro-N-{(3S)-1-[(1S)-1-methyl-2-(4-morpholinyl)-2-oxo ethyl]-2-oxo-3-pyrrolidinyl}-2-naphthalenesulfonamide
C21H24ClN3O5S (465.11251240000007)
Methyl 2-[[3-(1-benzylpyrazol-4-yl)phenyl]sulfonylamino]-4-fluorobenzoate
C24H20FN3O4S (465.11584920000007)
N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide
N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide
C21H21F2N3O5S (465.11699200000004)
3-(2,4-dimethoxyphenyl)-N-(3-fluoro-4-methylphenyl)-4-oxo-2-sulfanylidene-1H-quinazoline-7-carboxamide
C24H20FN3O4S (465.11584920000007)
(1S,10S,10aS)-3-(CONH2)-9-Cl-1-(Me2N)-3,3a,4,10-(HO)4-10-Me-2,5-dioxo-1H,10aH,11H,11aH-cyclopenta[b]anthracen-6-olate
3,5-dichloro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
3,5-dichloro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-2-oxanyl]ethyl]benzamide
2-acetamido-2-deoxy-3-O-(beta-D-Galp6S)-D-galactitol
[(2R,3R,4S,5S,6R)-2-[(2S,3R,4S,5R)-2-Acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate
YLF-466D
C29H20ClNO3 (465.1131640000001)
YLF-466D is a newly developed AMPK activator, which inhibits platelet aggregation.
methyl (10s)-5,10-dihydroxy-3-methoxy-7,19-dioxo-12,18-dioxa-17-azahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),2(15),3,5,13,20,22-heptaene-11-carboxylate
C24H19NO9 (465.10597640000003)